Nov 22, 2021

Featuring an interview with Professor Dr Arnon Kater, including the following topics:

• Novel agents and their use in combination therapies for chronic lymphocytic leukemia (CLL) (0:00)
• Case: A man in his late 70s with complex karyotype CLL with deletion 17p and a TP53 mutation (37:27)
• Case: A man in his early 50s with del(13q) and IGHV-mutated CLL treated with venetoclax/ibrutinib (44:24)
• Case: A woman in her early 70s with del(13q), del(17p) CLL with a TP53 mutation treated with ibrutinib monotherapy (47:18)

CME information and select publications